Biphasic Regulation of Lipid Metabolism: A Meta-Analysis of Icodextrin in Peritoneal Dialysis

BioMed Research International
Yan-Feng HuangWei-Jie Zhang

Abstract

The objective of this systematic meta-analysis was to study the impact of icodextrin (ICO) on lipid profiles. MEDLINE, PubMed, Embase, Chinese Biomedical Literature, and the Cochrane Library and Reference lists were searched (last search September 2014) in accordance with the Cochrane Handbook for Systematic Reviews of Interventions. Searches identified 13 eligible trials with a total of 850 patients. The differentials of total cholesterol (TC) and free fatty acid (FFA) in the ICO group were greater than those in the GLU group. Metaregression analysis showed that TC levels positively correlated with its baseline levels. In the subgroup of patients with dialysis duration more than 6 months, TC and TG in the ICO group were less. In pooled data from cross-sectional studies, differential of TG in the ICO group was less. In the subgroup of patients with diabetes (Martikainen et al., 2005, Sniderman et al., 2014, and Takatori et al., 2011), differential of high-density lipoprotein cholesterol (HDL-C) in the ICO group was less. There was no significant effect on low-density lipoprotein cholesterol (LDL-C), very low-density lipoprotein cholesterol (VLDL-C), or lipoprotein(a). ICO may be beneficial to lipid metabolism, especially for it...Continue Reading

References

Nov 20, 1998·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·R N FoleyM J Sarnak
Jun 17, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Koen J M van HoeckCornelis H Schroder
Mar 12, 2004·Nephrology·David W JohnsonMichael Suranyi
Jan 22, 2005·Seminars in Dialysis·John Burkart
Oct 14, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Ryuichi FuruyaAkira Hishida
Jun 1, 2006·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Arsalan N HabibAlexander S Goldfarb-Rumyantzev
Dec 26, 2006·Trends in Parasitology·Osamu Kunii
May 15, 2007·Renal Failure·Mustafa Canbakan, Gülizar Manga Sahin
Feb 28, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Philip Kam-Tao Li, Cheuk-Chun Szeto
May 3, 2008·Kidney International. Supplement·S G JohnC W McIntyre
Oct 8, 2009·Clinical Journal of the American Society of Nephrology : CJASN·Aiwu LinUNKNOWN Icodextrin National Multi-center Cooperation Group
Nov 12, 2009·JAMA : the Journal of the American Medical Association·UNKNOWN Emerging Risk Factors CollaborationJohn Danesh
Feb 11, 2010·Journal of Diabetes Science and Technology·Clifford J Holmes
Jun 23, 2010·Nature Reviews. Nephrology·Raymond T Krediet, Olga Balafa
Sep 30, 2010·Archives of Internal Medicine·Rajnish MehrotraEdward Vonesh
Apr 23, 2011·Clinical Journal of the American Society of Nephrology : CJASN·Uyen DuongKamyar Kalantar-Zadeh
Apr 2, 2013·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Marcin BarylskiUNKNOWN Lipid and Blood Pressure Meta-Analysis Collaboration Group
Sep 11, 2013·International Journal of Cardiology·Dragana NikolicUNKNOWN Lipid and Blood Pressure Meta-Analysis Collaboration Group
Aug 12, 2014·Journal of Clinical Lipidology·Allan D SnidermanJoanne M Bargman

❮ Previous
Next ❯

Citations

Jul 17, 2018·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Chieko HiguchiHiroshi Sakura

❮ Previous
Next ❯

Software Mentioned

Stata

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.